baseline white blood cell count ( wcc ) and haematocrit were examined in relation to recurrent coronary events and to all-cause mortality in 2026 persons enrolled in the first persantin-aspirin reinfarction study ( paris-1 ) 2-60 months after myocardial infarction .
C0004057
aspirin
C0027051
myocardial infarction